Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MyoCell catheter implantation in post-myocardial infarction congestive heart failure
2004-001922-26Phase 2Completed
- Sponsor
- Bioheart, Inc.
- Start
- Jun 2005
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of MyoCell in heart failure (HF) and myocardial infarction (MI) (2 arms), sponsored by Bioheart, Inc. Primary endpoints: Safety endpoints and Change in left ventricular ejection fraction. Started Jun 2005; status: completed.
02
Drugs
MyoCell
03
Conditions
heart failure (HF)myocardial infarction (MI)
Beyond the preview
Go deeper on 2004-001922-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001922-26.